Loading...

Intellectia LogoIntellectia
Auto Trade
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. HYEX
HYEX logo

HYEX Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--

Events Timeline

No data

No data

News

Newsfilter
5.0
2025-09-12Newsfilter
Gelteq Technology Supports U.S. Launch of Nutraceutical Products for Partner
  • Gelteq's U.S. Market Entry: Gelteq Limited has successfully transitioned from research and development to active commercialization in the U.S. market through its collaboration with Healthy Extracts, which has launched products utilizing Gelteq's gel-based delivery technology.

  • Growth Potential and Consumer Demand: The partnership highlights the potential for Gelteq's innovative gel technology in large-scale wellness markets, addressing consumer needs for convenient and clinically-informed nutraceutical solutions.

Benzinga
7.5
2025-06-10Benzinga
Gelteq Expands US Footprint With Healthy Extracts Logistics Deal, Stock Surges
  • Logistics Partnership Announcement: Gelteq Limited has partnered with Healthy Extracts Inc. to enhance its distribution network in North America, focusing on warehousing, shipping, and order fulfillment for its gel-based products.

  • Growth and Efficiency Goals: The partnership aims to improve operational efficiency, reduce costs, and support future product development, with distribution expected to start in Q3 2025, potentially increasing profit margins for both companies.

Newsfilter
7.5
2025-06-10Newsfilter
Gelteq Expands U.S. Operations with Healthy Extracts Inc. as North American Fulfillment Partner
SeekingAlpha
7.0
2025-01-14SeekingAlpha
Healthy Extracts expects 2024 net revenue to increase 24% Y/Y
  • Revenue Growth: Healthy Extracts expects its full year 2024 net revenue to exceed $3.1 million, representing a 24% increase year-over-year.

  • Recurring Revenue Boost: The company's "Subscribe & Save" program has significantly enhanced its recurring revenue stream, which has risen by 80% year-over-year.

Newsfilter
6.0
2024-12-02Newsfilter
Gelteq Announces Largest U.S. Customer Increases Initial Order by 50% to Meet Growing Market Demand
  • Gelteq's Partnership Expansion: Gelteq Limited has announced a 50% increase in the purchase order from its largest U.S. customer, Healthy Extracts, for collagen and sugar blocker gels due to high demand, supporting Gelteq's strategic growth in the U.S. market.

  • Innovative Delivery Solutions: Gelteq focuses on developing gel-based delivery solutions that improve ingestion and absorption of nutraceuticals, with plans to introduce new products in early 2025 as part of their collaboration with Healthy Extracts.

-.-
2024-04-02earning
Healthy Extracts GAAP EPS of -$0.85
Wall Street analysts forecast HYEX stock price to rise
0 Analyst Rating
Wall Street analysts forecast HYEX stock price to rise
0 Buy
0 Hold
0 Sell
Current: 0.000
sliders
Low
Averages
High
Current: 0.000
sliders
Low
Averages
High
No data

No data

Valuation Metrics

The current forward P/E ratio for (HYEX) is --, compared to its 5-year average forward P/E of --. For a more detailed relative valuation and DCF analysis to assess 's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PE
Current PE
NaN
Overvalued PE
Undervalued PE

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
Current EV/EBITDA
NaN
Overvalued EV/EBITDA
Undervalued EV/EBITDA

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
Current PS
NaN
Overvalued PS
Undervalued PS

Financials

AI Analysis
Annual
Quarterly

Whales Holding HYEX

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is (HYEX) stock price today?

The current price of HYEX is 0 USD — it has increased 0

What is (HYEX)'s business?

What is the price predicton of HYEX Stock?

Wall Street analysts forecast HYEX stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for HYEX is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is (HYEX)'s revenue for the last quarter?

revenue for the last quarter amounts to NaN USD, decreased

What is (HYEX)'s earnings per share (EPS) for the last quarter?

. EPS for the last quarter amounts to USD, decreased

How many employees does (HYEX). have?

(HYEX) has 0 emplpoyees as of March 07 2026.

What is (HYEX) market cap?

Today HYEX has the market capitalization of 0.00 USD.